These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14587438)

  • 1. [The production of pharmaceuticals in the world will become polarized].
    Eränkö P
    Duodecim; 2003; 119(17):1605-6. PubMed ID: 14587438
    [No Abstract]   [Full Text] [Related]  

  • 2. Hopes that Novartis deal on tuberculosis will spur donations for HIV and malaria.
    Fleck F
    BMJ; 2004 Jan; 328(7431):70. PubMed ID: 14715592
    [No Abstract]   [Full Text] [Related]  

  • 3. [GlaxoSmithKline again lowers prices of drugs for HIV/AIDS and malaria].
    Krankenpfl J; 2002; 40(7-9):222-3. PubMed ID: 12514863
    [No Abstract]   [Full Text] [Related]  

  • 4. Tobias, W.H.O. at odds over drug standards.
    Med Health; 2004 Mar; 58(13):2-3. PubMed ID: 15088496
    [No Abstract]   [Full Text] [Related]  

  • 5. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotics at the crossroads.
    Nathan C
    Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893
    [No Abstract]   [Full Text] [Related]  

  • 7. The essential medicines list for a global patient population.
    Robertson J; Hill SR
    Clin Pharmacol Ther; 2007 Nov; 82(5):498-500. PubMed ID: 17952104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential medicines for the whole world.
    Reidenberg MM
    Clin Pharmacol Ther; 2007 Nov; 82(5):500-3. PubMed ID: 17952105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trip into the unknown.
    Anderson T
    Nature; 2007 Nov; 450(7169):471. PubMed ID: 18033269
    [No Abstract]   [Full Text] [Related]  

  • 10. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global Health Impact Index: Promoting Global Health.
    Hassoun N
    PLoS One; 2015; 10(12):e0141374. PubMed ID: 26657064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 13. The African Comprehensive HIV/AIDS Partnerships--a new role for multinational corporations in global health policy.
    Distlerath LM; Macdonald G
    Yale J Health Policy Law Ethics; 2004; 4(1):147-55. PubMed ID: 15052865
    [No Abstract]   [Full Text] [Related]  

  • 14. World of scientific medicine.
    Hegde BM
    J Assoc Physicians India; 1998 Aug; 46(8):732-3. PubMed ID: 11229286
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiments in social responsibility.
    Herrling P
    Nature; 2006 Jan; 439(7074):267-8. PubMed ID: 16421547
    [No Abstract]   [Full Text] [Related]  

  • 16. GlaxoSmithKline, under pressure, cuts price of AIDS treatment for poor countries.
    Fleck F
    Bull World Health Organ; 2003; 81(6):469. PubMed ID: 12894339
    [No Abstract]   [Full Text] [Related]  

  • 17. The danger of in-kind drug donations to the Global Fund.
    Baker BK; Ombaka E
    Lancet; 2009 Apr; 373(9670):1218-21. PubMed ID: 18848353
    [No Abstract]   [Full Text] [Related]  

  • 18. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 19. TRIPS drug amendment a start.
    Webster P
    CMAJ; 2017 Feb; 189(7):E289. PubMed ID: 28246248
    [No Abstract]   [Full Text] [Related]  

  • 20. Are rich nations up for drug reform?
    Check E
    Nature; 2006 May; 441(7090):135. PubMed ID: 16688137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.